1954. A Randomized Study to Evaluate the Shedding and Immunogenicity of H1N1 Strains in Trivalent and Quadrivalent Formulations of FluMist in Children 24 to <48 Months of Age

por Mallory, Raburn, Nyborg, Andrew C, Kalyani, Rubana, Tsai, Lan-Feng, Block, Stan L, Dubovsky, Filip
Publicado 2018

Safety profile of anifrolumab in patients with active SLE: an integrated analysis of phase II and III trials

por Tummala, Raj, Abreu, Gabriel, Pineda, Lilia, Michaels, M Alex, Kalyani, Rubana N, Furie, Richard A, Morand, Eric F
Publicado 2021

Impact of SARS-CoV-2 infection on patients with systemic lupus erythematosus in England prior to vaccination: a retrospective observational cohort study

por Rabe, Adrian Paul J, Loke, Wei Jie, Kalyani, Rubana N, Tummala, Raj, Stirnadel-Farrant, Heide A, Were, John, Winthrop, Kevin L
Publicado 2023

Anifrolumab efficacy and safety by type I interferon gene signature and clinical subgroups in patients with SLE: post hoc analysis of pooled data from two phase III trials

por Vital, Edward M, Merrill, Joan T, Morand, Eric F, Furie, Richard A, Bruce, Ian N, Tanaka, Yoshiya, Manzi, Susan, Kalunian, Kenneth C, Kalyani, Rubana N, Streicher, Katie, Abreu, Gabriel, Tummala, Raj
Publicado 2022

Rationale and design of ASPIRE-ICU: a prospective cohort study on the incidence and predictors of Staphylococcus aureus and Pseudomonas aeruginosa pneumonia in the ICU

por Paling, Fleur P., Troeman, Darren P. R., Wolkewitz, Martin, Kalyani, Rubana, Prins, Daniël R., Weber, Susanne, Lammens, Christine, Timbermont, Leen, Goossens, Herman, Malhotra-Kumar, Surbhi, Sifakis, Frangiscos, Bonten, Marc J. M., Kluytmans, Jan A. J. W.
Publicado 2017